2017
DOI: 10.1186/s12859-017-1654-4
|View full text |Cite
|
Sign up to set email alerts
|

QueryOR: a comprehensive web platform for genetic variant analysis and prioritization

Abstract: BackgroundWhole genome and exome sequencing are contributing to the extraordinary progress in the study of human genetic variants. In this fast developing field, appropriate and easily accessible tools are required to facilitate data analysis.ResultsHere we describe QueryOR, a web platform suitable for searching among known candidate genes as well as for finding novel gene-disease associations. QueryOR combines several innovative features that make it comprehensive, flexible and easy to use. Instead of being d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 49 publications
0
19
0
Order By: Relevance
“…The bioinformatic analysis was performed on the Ion Torrent Server and the Torrent SuiteTM (https://ts-pgm.epigenetic.ru/ion-docs/Torrent-Variant-Caller-Plugin.html) for variant calling and to align the reads to the human genome reference 19 (hg19, https://grch37.ensembl.org/). Data were then analyzed by QueryOR web platform (https://queryor.cribi.unipd.it/cgi-bin/queryor/mainpage.pl) (Bertoldi et al., ) and genetic variants (missense, nonsense, indels) filtered for a global minor allele frequency ≤0.001, shared by the affected individuals but not present in five healthy controls. Multiple protein alignment was performed using the ClustalW software (https://www.ebi.ac.uk/Tools/msa/clustalo/).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The bioinformatic analysis was performed on the Ion Torrent Server and the Torrent SuiteTM (https://ts-pgm.epigenetic.ru/ion-docs/Torrent-Variant-Caller-Plugin.html) for variant calling and to align the reads to the human genome reference 19 (hg19, https://grch37.ensembl.org/). Data were then analyzed by QueryOR web platform (https://queryor.cribi.unipd.it/cgi-bin/queryor/mainpage.pl) (Bertoldi et al., ) and genetic variants (missense, nonsense, indels) filtered for a global minor allele frequency ≤0.001, shared by the affected individuals but not present in five healthy controls. Multiple protein alignment was performed using the ClustalW software (https://www.ebi.ac.uk/Tools/msa/clustalo/).…”
Section: Methodsmentioning
confidence: 99%
“…The CASQ1 mutations have been submitted to the locus-specific database (www.lovd.nl/CASQ1). (Bertoldi et al, 2017) and genetic variants (missense, nonsense, indels) filtered for a global minor allele frequency ≤0.001, shared by the affected individuals but not present in five healthy controls.…”
Section: Genetic Analysismentioning
confidence: 99%
“…Data were analyzed as suggested by the manufacturer, with read alignment using TMAP and variant calling with TSVC, which are both included in the Ion Proton Suite (v 5.0). QueryOR (http://queryor.cribi.unipd.it, accessed on 27 November 2019) [85] was used to analyze and prioritize short-nucleotide variants (SNV). This web-based query platform enables quick, easy, in-depth variant prioritization by aggregating several functional annotations of both genes and variants.…”
Section: Whole-exome Sequencing (Wes)mentioning
confidence: 99%
“…In order to overcome these difficulties, another generation of (freely available) tools have been developed that incorporate a rare disease patient's phenotype into the interpretation of their sequencing data. These include eXtasy [34], BiERapp [35], Phen-Gen [36], Exomiser [37], Phevor [38], PhenoVar [39], PhenIX [40], OVA [41], Phenolyzer [42], wANNOVAR [43], OMIM Explorer [44], QueryOR [45], GenIO [46], DeepPVP [47], MutationDistiller [48], Phrank [49], Xrare [50], PhenoPro [51], and Phenoxome [52]. Such phenotype-driven prioritization tools leverage existing genotype to phenotype information from various databases in order to prioritize candidate variants in those genes that are likely to be more relevant to the patient's phenotype.…”
Section: Introductionmentioning
confidence: 99%